Abbott Labs (ABT) PT Lowered to $106 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Mike Kratky lowered the price target on Abbott Labs (NYSE: ABT) to $106.00 (from $119.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
